Coming of age: the artificial pancreas for type 1 diabetes Hood ThabitRoman Hovorka Review Open access 30 June 2016 Pages: 1795 - 1805
Novel phenotypes of prediabetes? Hans-Ulrich Häring Review Open access 25 June 2016 Pages: 1806 - 1818
Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease Michelle J. PenaHarald MischakHiddo J. L. Heerspink Review Open access 25 June 2016 Pages: 1819 - 1831
Sources of beta cells inside the pancreas Sofie De GroefWillem StaelsHarry Heimberg Mini-review 06 April 2016 Pages: 1834 - 1837
Targeting insulin-producing beta cells for regenerative therapy Adriana MiglioriniSara S. RoscioniHeiko Lickert Mini-review 13 July 2016 Pages: 1838 - 1842
MST1: a promising therapeutic target to restore functional beta cell mass in diabetes Amin ArdestaniKathrin Maedler Mini-Review 06 April 2016 Pages: 1843 - 1849
Can genetic evidence help us to understand the fetal origins of type 2 diabetes? Rachel M. Freathy Commentary 19 July 2016 Pages: 1850 - 1854
Cocaine- and amphetamine-regulated transcript: a novel regulator of energy homeostasis expressed in a subpopulation of pancreatic islet cells Patrick Gilon Commentary 15 July 2016 Pages: 1855 - 1859
The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes David CherneySøren S. LundMaximilian von Eynatten Article 17 June 2016 Pages: 1860 - 1870
Neonatal vitamin D status is not associated with later risk of type 1 diabetes: results from two large Danish population-based studies Ramune JacobsenSteffen U. ThorsenBerit L. Heitmann Article 30 May 2016 Pages: 1871 - 1881
MASP1, THBS1, GPLD1 and ApoA-IV are novel biomarkers associated with prediabetes: the KORA F4 study Christine von ToerneCornelia HuthStefanie M. Hauck Article 25 June 2016 Pages: 1882 - 1892
The association of ideal cardiovascular health with incident type 2 diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis Joshua J. JosephJustin B. Echouffo-TcheuguiSherita H. Golden Article 08 June 2016 Pages: 1893 - 1903
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study S. Goya WannametheePaul WelshNaveed Sattar Article Open access 16 June 2016 Pages: 1904 - 1912
Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS) Katharina A. PontoJochem KoenigAlireza Mirshahi Article 17 June 2016 Pages: 1913 - 1919
Low birthweight and risk of type 2 diabetes: a Mendelian randomisation study Tiange WangTao HuangLu Qi Article 23 June 2016 Pages: 1920 - 1927
CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion Mia AbelsMatteo RivaNils Wierup Article 23 June 2016 Pages: 1928 - 1937
Cell type-specific deletion in mice reveals roles for PAS kinase in insulin and glucagon production Francesca SempliciAngeles MondragonGuy A. Rutter Article Open access 24 June 2016 Pages: 1938 - 1947
A combination of cytokines EGF and CNTF protects the functional beta cell mass in mice with short-term hyperglycaemia Marie LemperSofie De GroefHarry Heimberg Article 18 June 2016 Pages: 1948 - 1958
RNA-binding protein CUGBP1 regulates insulin secretion via activation of phosphodiesterase 3B in mice Kui ZhaiLei GuGuangju Ji Article 02 June 2016 Pages: 1959 - 1967
Pancreatic perfusion and subsequent response to glucose in healthy individuals and patients with type 1 diabetes Lina CarlbomDaniel EspesPer-Ola Carlsson Short Communication 16 June 2016 Pages: 1968 - 1972
Tetraspanin 7 autoantibodies in type 1 diabetes Denise WaltherAnne EugsterEzio Bonifacio Short Communication 25 May 2016 Pages: 1973 - 1976
In vivo PET imaging with [18F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes Blake J. CochranWilliam J. RyderKerry-Anne Rye Article 18 May 2016 Pages: 1977 - 1984
Redundant roles of the phosphatidate phosphatase family in triacylglycerol synthesis in human adipocytes Ana TempranoHiroshi SembongiMerce Miranda Article Open access 25 June 2016 Pages: 1985 - 1994
Adipocyte-specific deletion of mTOR inhibits adipose tissue development and causes insulin resistance in mice Tizhong ShanPengpeng ZhangShihuan Kuang Article 13 June 2016 Pages: 1995 - 2004
Treatment of diet-induced lipodystrophic C57BL/6J mice with long-acting PASylated leptin normalises insulin sensitivity and hepatic steatosis by promoting lipid utilisation Florian BolzeAndrea BastMartin Klingenspor Article 07 June 2016 Pages: 2005 - 2012
Energy restriction and Roux-en-Y gastric bypass reduce postprandial α-dicarbonyl stress in obese women with type 2 diabetes Dionne E. MaessenNordin M. HanssenCasper G. Schalkwijk Short Communication Open access 16 June 2016 Pages: 2013 - 2017
Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes Emily J. GallagherZara ZelenkoDerek LeRoith Article 30 May 2016 Pages: 2018 - 2025
Extravascular modified lipoproteins: a role in the propagation of diabetic retinopathy in a mouse model of type 1 diabetes Jeremy Y. YuMei DuTimothy J. Lyons Article Open access 15 June 2016 Pages: 2026 - 2035
Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment Paola FiorettoBergur V. StefanssonC. David Sjöström Research Letter Open access 15 June 2016 Pages: 2036 - 2039
Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy Bruno HalpernCintia CercatoMarcio C. Mancini Letter 16 June 2016 Pages: 2040 - 2041
Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy. Reply to Halpern B, Cercato C, Mancini MC [letter] David E. Cummings Letter 07 July 2016 Pages: 2042 - 2044
